摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯-5-乙氧基苯基硼酸 | 913835-30-0

中文名称
2-氯-5-乙氧基苯基硼酸
中文别名
2-氯-5-乙氧基苯硼酸
英文名称
(2-chloro-5-ethoxyphenyl)boronic acid
英文别名
2-chloro-5-ethoxyphenylboronic acid
2-氯-5-乙氧基苯基硼酸化学式
CAS
913835-30-0
化学式
C8H10BClO3
mdl
MFCD08235081
分子量
200.43
InChiKey
LIFPTULDIUUUBK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    98-100
  • 沸点:
    363.2±52.0 °C(Predicted)
  • 密度:
    1.27±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.25
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    49.7
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2931900090
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P302+P352,P304+P340,P305+P351+P338,P312,P330,P362,P403+P233,P501
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:90c1ef3cbcfa1e07b10cafcb3b773a42
查看
Material Safety Data Sheet

Section 1. Identification of the substance
2-Chloro-5-ethoxyphenylboronic acid
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
2-Chloro-5-ethoxyphenylboronic acid
Ingredient name:
CAS number: 913835-30-0

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H10BClO3
Molecular weight: 200.4

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    9-(3,5-dichlorophenyl)-2-methoxy-6,7-dimethylimidazo[1,5-a]pyrido[3,2-e]pyrazine 、 2-氯-5-乙氧基苯基硼酸 在 silica gel 、 ethyl acetate n-hexane 作用下, 生成 9-(2-chloro-5-ethoxyphenyl)-2-methoxy-6,7-dimethylimidazo[1,5-a]pyrido[3,2-e]pyrazine
    参考文献:
    名称:
    Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10
    摘要:
    本发明涉及吡啶并[3,2-e]吡嗪、其制备方法、包含这些化合物的制药组合物以及这些化合物的药物用途,它们是磷酸二酯酶10的抑制剂,作为治疗中枢神经系统疾病、肥胖症和代谢紊乱的活性化合物。
    公开号:
    US20090143361A1
  • 作为产物:
    描述:
    硼酸三异丙酯 、 1-chloro-2-iodo-4-ethoxybenzene 在 正丁基锂 作用下, 以 四氢呋喃正己烷 为溶剂, 以59%的产率得到2-氯-5-乙氧基苯基硼酸
    参考文献:
    名称:
    5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS
    摘要:
    本发明涉及5,6-双芳基-2-吡啶甲酰胺衍生物,其制备以及其作为尿苷Ⅱ受体拮抗剂在治疗学中的应用。
    公开号:
    US20090318473A1
点击查看最新优质反应信息

文献信息

  • 5, 6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS
    申请人:Altenburger Jean-Michel
    公开号:US20120108611A1
    公开(公告)日:2012-05-03
    The present invention relates to derivatives of 5,6-bisaryl-2-pyridine-carboxamide, their preparation and their application in therapeutics as antagonists of urotensin II receptors.
    本发明涉及5,6-双芳基-2-吡啶羧酰胺衍生物,它们的制备以及它们作为尿泰松II受体拮抗剂在治疗学中的应用。
  • 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
    申请人:Sanofi-Aventis
    公开号:US08110579B2
    公开(公告)日:2012-02-07
    The present invention relates to derivatives of 5,6-bisaryl-2-pyridine-carboxamide, their preparation and their application in therapeutics as antagonists of urotensin II receptors.
    本发明涉及5,6-双芳基-2-吡啶羧酰胺衍生物,其制备方法以及作为尿加压素II受体拮抗剂在治疗领域的应用。
  • 5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
    申请人:Altenburger Jean-Michel
    公开号:US08552201B2
    公开(公告)日:2013-10-08
    The present invention relates to derivatives of 5,6-bisaryl-2-pyridine-carboxamide, their preparation and their application in therapeutics as antagonists of urotensin II receptors.
    本发明涉及5,6-双芳基-2-吡啶羧酰胺衍生物,其制备以及其作为尿腺素II受体拮抗剂在治疗学中的应用。
  • 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS
    申请人:Altenburger Jean-Michel
    公开号:US20090318473A1
    公开(公告)日:2009-12-24
    The present invention relates to derivatives of 5,6-bisaryl-2-pyridine-carboxamide, their preparation and their application in therapeutics as antagonists of urotensin II receptors.
    本发明涉及5,6-双芳基-2-吡啶甲酰胺衍生物,其制备以及其作为尿苷Ⅱ受体拮抗剂在治疗学中的应用。
  • Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10
    申请人:Malamas Michael S.
    公开号:US20090143361A1
    公开(公告)日:2009-06-04
    The invention relates to pyrido[3,2-e]pyrazines, to processes for preparing them, to pharmaceutical compositions which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 10, as active compounds for treating central nervous system disorders, obesity, and metabolic disorders.
    本发明涉及吡啶并[3,2-e]吡嗪、其制备方法、包含这些化合物的制药组合物以及这些化合物的药物用途,它们是磷酸二酯酶10的抑制剂,作为治疗中枢神经系统疾病、肥胖症和代谢紊乱的活性化合物。
查看更多